Endocrine immune-related adverse event is a prognostic biomarker independent of lead-time bias. Ishidoya M, Makiguchi T, Tanaka H, Miura T, et al. Lung Cancer 2024;192:107790.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ishidoya M, Makiguchi T, Tanaka H, Miura T, et al. Endocrine immune-related adverse event is a prognostic biomarker independent of lead-time bias. Lung Cancer 2024;192:107790.
PMID: 38696920